Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension

• Status: Completed
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine Korean red ginseng (KRG)treatment could decrease central blood pressure in subjects with hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daegu Catholic University Medical Center
• Collaborator: The Korean Society of Ginseng

Criteria

Inclusion Criteria:

• Essential hypertension

• diastolic blood pressure 100 mmHg or less and systolic blood pressure 160 mmHg or less

Exclusion Criteria:

• Secondary hypertension

• Serum creatinin above 1.5 mg/dL

• aspartate aminotransferase(AST) and alanine aminotransferaseALT above two times upper normal limits

• Uncontrolled diabetes (Hb A1c < 9%)

• Acute myocardial infarction or coronary artery disease intervention within six months

• Moderate to severe congestive heart failure

• HIV positive

• Immunocompromized host

• Allergy to Korean red ginseng

• Pregnancy or plan to pregnancy

• Alcohol or drug abuse

• Attend to other clinical trial within 12 weeks